Skip to Main Content
Volastra

News & Views

Latest Updates

Volastra Therapeutics Co-founder Samuel Bakhoum to Deliver Plenary Presentation at American Association for Cancer Research Annual Meeting 2021

April 8, 2021
Dr. Bakhoum will present on the critical role of chromosomal instability in cancer metastasis. NEW...

Volastra Therapeutics Extends Seed Financing to $44 Million to Advance Drug Discovery Programs to Prevent Cancer Metastasis

April 6, 2021
Company founded by Polaris Partners with latest financing led by Vida Ventures  Funding will support...

Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research

April 6, 2021
Collaboration will integrate Microsoft Azure AI and Volastra’s insights into tumor biology to develop machine...
Load More

Our Perspectives

Shining a light on chromosomal instability at AACR 2021

April 13, 2021
Search any biology textbook for its description of cancer and you’ll likely find the phrase...

In The News

Researchers see a ‘tractable approach’ to taming cancer metastasis

April 8, 2021
STAT

Volastra, Microsoft team up to battle cancer

April 7, 2021
Wall Street Journal

With fresh investor cash in hand, Volastra partners with Microsoft to develop metastatic cancer biomarker platform

April 6, 2021
Endpoints
Load More

Contact Us

Volastra
1361 Amsterdam Ave Suite 520
New York, NY 10027
Phone: (646) 344-1248
contactus@volastratx.com

Media Contact
Lisa Qu
Ten Bridge Communications
678-662-9166
LQu@tenbridgecommunications.com